|
|
Volumn 252, Issue , 2004, Pages 437-450
|
|
RNase P ribozyme as an antiviral agent against human cytomegalovirus.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIVIRUS AGENT;
PRIMER DNA;
RIBONUCLEASE P;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ARTICLE;
CYTOMEGALOVIRUS;
DRUG EFFECT;
GENE TARGETING;
GENETIC DISORDER;
GENETICS;
GROWTH, DEVELOPMENT AND AGING;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
METHODOLOGY;
MOLECULAR GENETICS;
NEWBORN;
NORTHERN BLOTTING;
NUCLEOTIDE SEQUENCE;
POLYMERASE CHAIN REACTION;
PROMOTER REGION;
ACQUIRED IMMUNODEFICIENCY SYNDROME;
ANTIVIRAL AGENTS;
BASE SEQUENCE;
BLOTTING, NORTHERN;
CYTOMEGALOVIRUS;
DNA PRIMERS;
GENE TARGETING;
GENETIC DISEASES, INBORN;
HIV-1;
HUMANS;
INFANT, NEWBORN;
MOLECULAR SEQUENCE DATA;
POLYMERASE CHAIN REACTION;
PROMOTER REGIONS (GENETICS);
RIBONUCLEASE P;
MLCS;
MLOWN;
|
|
EID: 2942729624
PISSN: 10643745
EISSN: None
Source Type: Journal
DOI: 10.1385/1-59259-746-7:437 Document Type: Article |
|
Times cited : (1)
|
|
References (0)
|
